Jennifer L Moss1, Ming Wang2, Menglu Liang2, Alain Kameni2, Kelsey C Stoltzfus2, Tracy Onega3. 1. Penn State College of Medicine, Hershey, PA, USA. Electronic address: jmoss1@pennstatehealth.psu.edu. 2. Penn State College of Medicine, Hershey, PA, USA. 3. Huntsman Cancer Institute, Salt Lake City, UT, USA; University of Utah, Salt Lake City, UT, USA.
Abstract
BACKGROUND: Cancer screening differs by rurality and racial residential segregation, but the relationship between these county-level characteristics is understudied. Understanding this relationship and its implications for cancer outcomes could inform interventions to decrease cancer disparities. METHODS: We linked county-level information from national data sources: 2008-2012 cancer incidence, late-stage incidence, and mortality rates (for breast, cervical, and colorectal cancer) from U.S. Cancer Statistics and the National Death Index; metropolitan status from U.S. Department of Agriculture; residential segregation derived from American Community Survey; and prevalence of cancer screening from National Cancer Institute's Small Area Estimates. We used multivariable, sparse Poisson generalized linear mixed models to assess cancer incidence, late-stage incidence, and mortality rates by county-level characteristics, controlling for density of physicians and median household income. RESULTS: Cancer incidence, late-stage incidence, and mortality rates were 6-18% lower in metropolitan counties for breast and colorectal cancer, and 2-4% lower in more segregated counties for breast and colorectal cancer. Generally, reductions in cancer associated with residential segregation were limited to non-metropolitan counties. Cancer incidence, late-stage incidence, and mortality rates were associated with screening, with rates for corresponding cancers that were 2-9% higher in areas with more breast and colorectal screening, but 2-15% lower in areas with more cervical screening. DISCUSSION: Lower cancer burden was observed in counties that were metropolitan and more segregated. Effect modification was observed by metropolitan status and county-level residential segregation, indicating that residential segregation may impact healthcare access differently in different county types. Additional studies are needed to inform interventions to reduce county-level disparities in cancer incidence, late-stage incidence, and mortality.
BACKGROUND: Cancer screening differs by rurality and racial residential segregation, but the relationship between these county-level characteristics is understudied. Understanding this relationship and its implications for cancer outcomes could inform interventions to decrease cancer disparities. METHODS: We linked county-level information from national data sources: 2008-2012 cancer incidence, late-stage incidence, and mortality rates (for breast, cervical, and colorectal cancer) from U.S. Cancer Statistics and the National Death Index; metropolitan status from U.S. Department of Agriculture; residential segregation derived from American Community Survey; and prevalence of cancer screening from National Cancer Institute's Small Area Estimates. We used multivariable, sparse Poisson generalized linear mixed models to assess cancer incidence, late-stage incidence, and mortality rates by county-level characteristics, controlling for density of physicians and median household income. RESULTS: Cancer incidence, late-stage incidence, and mortality rates were 6-18% lower in metropolitan counties for breast and colorectal cancer, and 2-4% lower in more segregated counties for breast and colorectal cancer. Generally, reductions in cancer associated with residential segregation were limited to non-metropolitan counties. Cancer incidence, late-stage incidence, and mortality rates were associated with screening, with rates for corresponding cancers that were 2-9% higher in areas with more breast and colorectal screening, but 2-15% lower in areas with more cervical screening. DISCUSSION: Lower cancer burden was observed in counties that were metropolitan and more segregated. Effect modification was observed by metropolitan status and county-level residential segregation, indicating that residential segregation may impact healthcare access differently in different county types. Additional studies are needed to inform interventions to reduce county-level disparities in cancer incidence, late-stage incidence, and mortality.
Authors: Jonathan M Loree; Khodadad R Javaheri; Shilo V Lefresne; Caroline H Speers; Jenny Y Ruan; Jennifer T Chang; Carl J Brown; Hagen F Kennecke; Robert A Olson; Winson Y Cheung Journal: J Rural Health Date: 2016-10-07 Impact factor: 4.333
Authors: Christina A Clarke; Sally L Glaser; Dee W West; Rochelle R Ereman; Christine A Erdmann; Janice M Barlow; Margaret R Wrensch Journal: Breast Cancer Res Date: 2002-07-26 Impact factor: 6.466
Authors: Caitlin V McCowan; Duncan Salmon; Jingzhe Hu; Shivanand Pudakalakatti; Nicholas Whiting; Jennifer S Davis; Daniel D Carson; Niki M Zacharias; Pratip K Bhattacharya; Mary C Farach-Carson Journal: Diagnostics (Basel) Date: 2022-03-01